Safety and Antibody Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Kidney Transplant Recipients

• DOI: 10.26502/jesph.96120140
• Publication Date: 2021-10-05T11:13:09Z
• Authors: Ali AlShaqaq; Maher AlDemerdash; Abdulnaser AlAbadi; Baher Elgadaa; Najib Musaied; Ibtihal Shaikh; Omar Abed; Sumayah Askandarani; Khaled Hamawi; Fahad E. AlOtaibe; Khalid Bel’eed Ak...; Meteb M AlBugami
• Keywords: 2019-20 coronavirus outbreak; Antibody response; Coronavirus Infections; Pandemic

Background and objectives: Corona virus disease 2019 (COVID-19) is associated with significant morbidity mortality in kidney transplant recipients (KTRs). Therefore, they are considered among the priority group for vaccination. This study presents safety data antibody response to BNT162b2 ChAdOx1 nCoV-19 vaccines KTRs.